) has been revised to $11.37 / share. This is an increase of 11.43% from the prior estimate of $10.20 dated March 25, 2026. The price target is an average of many targets provided by analysts. The ...
Ocugen, Inc. (NASDAQ:OCGN) is one of the 10 Best High-Risk Penny Stocks to Buy Right Now. Ocugen, Inc. (NASDAQ:OCGN) released its fourth-quarter fiscal 2025 results on March 4. The company reported ...
The average one-year price target for Ocugen (NasdaqCM:OCGN) has been revised to $8.36 / share. This is an increase of 26.15% from the prior estimate of $6.63 dated September 27, 2025. The price ...
Ocugen’s OCU400 Phase 3 plus Korean licensing underpin potential 2026 BLA remains the company’s best bet at its first commercial gene therapy revenue. OCU410ST also received a Rare Pediatric Disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results